MLTX

MoonLake Immunotherapeutics
MLTX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$2.62B
EV
$2.18B
Shares Outstanding
63.38M
Beta
1.31

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$78.08
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About MoonLake Immunotherapeutics

gainify
MLTX

MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spo...

Sector

Healthcare

Industry

Biotechnology

CEO

da Silva, Jorge

Employees

100

IPO Date

2020-10-20

Headquarters

Dorfstrasse 29, Zug, Zug, 6300, Switzerland

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved